Prevalence of Subacromial Impingement Among Egyptian Swimmers (NCT05548816) | Clinical Trial Compass
CompletedNot Applicable
Prevalence of Subacromial Impingement Among Egyptian Swimmers
Egypt405 participantsStarted 2022-08-30
Plain-language summary
In the available literature, there are no prevalence studies that show the incidence of subacromial impingement in swimmers in Egypt, this should be considered as it's one of the most commonly reported injuries worldwide in swimmers. There are also no available studies to show the difference in incidence of subacromial impingement between both genders in Egypt. This study is attempting to remedy both research deficits and to reduce the literature gap and to show the prevalence rate of this injury among Egyptian swimmers in different age groups, to help prevent its widespread and to provide data for further investigations. This study would give the Egyptian swimming federation and the Ministry of youth and sports a clear idea about the prevalence rate of swimmer's shoulder at different ages in Egyptian swimmers. Most importantly, this study is to provide the physiotherapy community in Egypt data about this injury, the rate of prevalence and how to prevent it and hopefully would help in further future studies and also to apply it in different countries.
Who can participate
Age range
12 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 440 swimmers (males and females) , their age between 12 - 25.
* Professional swimmers only.
* Complain of anterior shoulder pain while swimming or elevation of shoulder.
* BMI will be ranged from (18.5 - 24.9 kg/m2 ).
* All swimmers are under supervision and psychologically, medically stable.
* All swimmers received a good explanation of the questionnaire and the given study.
Exclusion Criteria:
* Any swimmer who refuse to participate in the study
* Uncooperative swimmers.
* Unprofessional swimmers.
* Participants who play any other sports.
* Exclude any previous traumatic lesion.
* Exclude any form of shoulder instability.
* Take any medication that affects pain perception as NSAIDS.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.